Stay updated with breaking news from Karin Straathof. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A mother whose young daughter survived cancer claimed that new treatments could help every family have a happy ending like hers.
Seven scientists at UCL will take on some of the toughest obstacles in cancer, after being selected to play leading roles in the latest global Cancer Grand Challenges.
Read Time: The largest single cell study to date of the childhood cancer, neuroblastoma, has answered important questions about the genesis of the disease. The researchers from the Wellcome Sanger Institute, Great Ormond Street Hospital (GOSH) and the Princess Máxima Center for Pediatric Oncology, discovered that all neuroblastomas arise from a single type of embryonic cell called sympathoblasts. The study, published today (5 February 2021) in Science Advances, sought to understand why neuroblastomas range in severity, with some easy to treat and others having relatively low five-year su...
Single Cell Type Identified as Neuroblastoma Target February 8, 2021 Source: National Cancer Institute; photograph by Bill Branson Through what they claim is the largest single cell study of neuroblastoma carried out to date, researchers from the Wellcome Sanger Institute, Great Ormond Street Hospital (GOSH), and the Princess Máxima Center for Pediatric Oncology, have found the answers to important questions about the genesis of this childhood cancer. Their results indicate that all neuroblastomas arise from a single type of embryonic cell, known as sympathoblasts, which could point to new...
E-Mail The largest single cell study to date of the childhood cancer, neuroblastoma, has answered important questions about the genesis of the disease. The researchers from the Wellcome Sanger Institute, Great Ormond Street Hospital (GOSH) and the Princess Máxima Center for Pediatric Oncology, discovered that all neuroblastomas arise from a single type of embryonic cell called sympathoblasts. The study, published today (5 February 2021) in Science Advances, sought to understand why neuroblastomas range in severity, with some easy to treat and others having relatively low five-year surviva...